J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

J B Chemicals & Pharmaceuticals Ltd

₹ 1,792 -1.68%
18 Nov 3:40 p.m.
jbpharma.com BSE: 506943 NSE: JBCHEPHARM
About

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]

Key Points

Revenue Split H1FY24
Domestic Formulations - 55%
Export Formulations - 30%
Contract Manufacturing - 13%
APIs - 2% [1]

Website BSE NSE
  • Market Cap ₹ 28,057 Cr.
  • Current Price ₹ 1,792
  • High / Low ₹ 1,952 / 1,303
  • Stock P/E 39.0
  • Book Value ₹ 243
  • Dividend Yield 0.86 %
  • ROCE 25.8 %
  • ROE 20.1 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 19.8% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 34.8%

Cons

  • Stock is trading at 7.39 times its book value
  • Promoter holding has decreased over last 3 years: -6.40%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Pharma

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
809 793 762 896 882 845 862 1,004 1,001 963 949 1,094 1,085
625 618 599 664 638 621 664 724 730 709 723 793 775
Operating Profit 185 175 164 232 244 223 198 280 271 255 226 301 310
OPM % 23% 22% 21% 26% 28% 26% 23% 28% 27% 26% 24% 28% 29%
1 3 5 6 8 7 17 6 10 8 14 15 15
Interest 8 8 14 12 10 12 9 6 2 3 1 1 1
Depreciation 28 28 32 31 32 34 41 41 42 42 46 43 44
Profit before tax 150 141 122 194 209 184 165 240 237 218 193 272 279
Tax % 26% 25% 28% 27% 28% 27% 23% 26% 26% 25% 25% 25% 26%
111 106 88 142 151 134 126 177 175 162 146 202 208
EPS in Rs 7.18 6.86 5.66 9.19 9.72 8.61 8.13 11.39 11.24 10.45 9.36 12.97 13.27
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1,022 1,144 1,210 1,344 1,408 1,643 1,775 2,043 2,424 3,149 3,484 3,918 4,092
874 964 1,004 1,112 1,191 1,337 1,397 1,482 1,881 2,454 2,587 2,886 3,000
Operating Profit 148 180 206 232 218 306 378 560 543 696 897 1,032 1,091
OPM % 14% 16% 17% 17% 15% 19% 21% 27% 22% 22% 26% 26% 27%
-27 11 58 50 37 41 41 112 39 10 37 38 52
Interest 6 7 11 5 3 5 3 7 5 36 44 12 6
Depreciation 28 39 41 47 57 56 66 69 73 114 138 171 176
Profit before tax 87 146 212 230 194 287 349 597 505 555 752 887 962
Tax % 30% 31% 23% 20% 28% 32% 22% 25% 24% 26% 26% 26%
62 100 163 184 139 194 272 449 386 410 553 660 718
EPS in Rs 3.63 5.92 9.58 10.85 8.28 12.05 17.60 28.98 24.93 26.48 35.61 42.37 46.05
Dividend Payout % 41% 118% 26% 5% 12% 21% 31% 28% 33% 34% 34% 37%
Compounded Sales Growth
10 Years: 13%
5 Years: 17%
3 Years: 17%
TTM: 10%
Compounded Profit Growth
10 Years: 21%
5 Years: 20%
3 Years: 21%
TTM: 18%
Stock Price CAGR
10 Years: 30%
5 Years: 31%
3 Years: 20%
1 Year: 8%
Return on Equity
10 Years: 17%
5 Years: 20%
3 Years: 19%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 17 17 17 17 17 16 15 15 15 15 16 16 16
Reserves 1,026 978 1,167 1,347 1,425 1,464 1,420 1,794 2,119 2,465 2,908 3,418 3,790
93 127 193 49 29 26 29 45 55 572 378 28 19
215 365 270 262 294 286 349 376 412 495 687 804 887
Total Liabilities 1,351 1,487 1,648 1,674 1,765 1,792 1,814 2,231 2,601 3,547 3,988 4,265 4,712
311 329 440 679 640 621 651 634 1,277 1,901 2,004 1,968 1,977
CWIP 46 55 135 4 17 15 16 26 19 55 76 63 32
Investments 500 552 479 411 434 457 403 678 13 206 388 345 519
494 552 594 580 674 699 743 894 1,293 1,385 1,519 1,889 2,184
Total Assets 1,351 1,487 1,648 1,674 1,765 1,792 1,814 2,231 2,601 3,547 3,988 4,265 4,712

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-14 127 140 201 123 194 276 315 170 626 801 902
-142 -112 -26 -45 -21 -28 24 -231 2 -962 -404 -296
12 -1 -100 -184 -60 -156 -306 -87 -138 357 -385 -580
Net Cash Flow -144 13 15 -28 43 11 -6 -3 34 20 11 27

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 84 84 82 72 78 68 71 70 84 67 72 76
Inventory Days 120 122 146 138 145 149 159 181 178 134 155 147
Days Payable 54 63 71 68 75 72 97 97 97 75 110 114
Cash Conversion Cycle 150 143 158 142 148 146 133 153 164 127 117 109
Working Capital Days 70 16 38 75 93 91 81 91 122 81 55 79
ROCE % 13% 13% 15% 14% 11% 18% 23% 33% 23% 22% 25% 26%

Shareholding Pattern

Numbers in percentages

18 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
53.95% 53.93% 53.91% 53.86% 53.83% 53.78% 53.77% 53.74% 53.66% 47.84% 47.73% 47.56%
8.81% 8.62% 9.53% 10.05% 10.35% 11.06% 12.17% 13.63% 14.64% 18.30% 17.77% 15.31%
18.55% 19.08% 18.65% 18.58% 18.53% 18.38% 17.61% 16.81% 16.40% 18.71% 19.62% 22.83%
0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00% 0.01% 0.00% 0.00% 0.00% 0.00%
18.72% 18.35% 17.90% 17.50% 17.27% 16.78% 16.42% 15.80% 15.29% 15.13% 14.87% 14.31%
No. of Shareholders 59,77956,63355,96560,81763,23063,89266,95362,74362,08163,94870,06471,957

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls